These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31932967)

  • 41. Plasma Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 as Prognostic Biomarkers in Critically Ill Patients.
    Duda I; Krzych Ł; Jędrzejowska-Szypułka H; Lewin-Kowalik J
    Open Med (Wars); 2020; 15():50-56. PubMed ID: 32190734
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effects of circadian heart rate variation on short-term and long-term mortality in intensive care unit patients: a retrospective cohort study based on MIMIC-II database].
    Luo Y; Zhang J; Li R; Gao Y; Hou Y; Li J; Wang X; Wang G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Sep; 31(9):1128-1132. PubMed ID: 31657338
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased expression of extracellular matrix regulators TIMP1 and MMP1 in deteriorating heart failure.
    Barton PJ; Birks EJ; Felkin LE; Cullen ME; Koban MU; Yacoub MH
    J Heart Lung Transplant; 2003 Jul; 22(7):738-44. PubMed ID: 12873541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit.
    Feldman LJ; Mazighi M; Scheuble A; Deux JF; De Benedetti E; Badier-Commander C; Brambilla E; Henin D; Steg PG; Jacob MP
    Circulation; 2001 Jun; 103(25):3117-22. PubMed ID: 11425778
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Matrix metalloproteinases -8 and -9 and tissue inhibitor of metalloproteinase-1 in burn patients. A prospective observational study.
    Hästbacka J; Fredén F; Hult M; Bergquist M; Wilkman E; Vuola J; Sorsa T; Tervahartiala T; Huss F
    PLoS One; 2015; 10(5):e0125918. PubMed ID: 25945788
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes of plasma acetylcholine and inflammatory markers in critically ill patients during early enteral nutrition: A prospective observational study.
    Tao G; Min-Hua C; Feng-Chan X; Yan C; Ting S; Wei-Qin L; Wen-Kui Y
    J Crit Care; 2019 Aug; 52():219-226. PubMed ID: 31108325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic Value of Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis-Associated Acute Kidney Injury.
    Bojic S; Kotur-Stevuljevic J; Kalezic N; Stevanovic P; Jelic-Ivanovic Z; Bilanovic D; Memon L; Damnjanovic M; Kalaba Z; Simic-Ogrizovic S
    Tohoku J Exp Med; 2015 Oct; 237(2):103-9. PubMed ID: 26399271
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure.
    George J; Patal S; Wexler D; Roth A; Sheps D; Keren G
    Am Heart J; 2005 Sep; 150(3):484-7. PubMed ID: 16169329
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma tissue inhibitor of matrix metalloproteinase-1 a predictor of long-term mortality in patients treated with cardiac resynchronization therapy.
    Trucco E; Tolosana JM; Castel MÁ; Batlle M; Borràs R; Sitges M; Guash E; Matas M; Arbelo E; Berruezo A; Brugada J; Mont L
    Europace; 2016 Feb; 18(2):232-7. PubMed ID: 25883077
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction.
    Lorente L; Martín MM; Ramos L; Cáceres JJ; Solé-Violán J; Argueso M; Jiménez A; Borreguero-León JM; Orbe J; Rodríguez JA; Páramo JA
    BMC Neurol; 2015 Jul; 15():111. PubMed ID: 26162891
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Critical care in the emergency department: A physiologic assessment and outcome evaluation.
    Nguyen HB; Rivers EP; Havstad S; Knoblich B; Ressler JA; Muzzin AM; Tomlanovich MC
    Acad Emerg Med; 2000 Dec; 7(12):1354-61. PubMed ID: 11099425
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynamic changes of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 after burn injury.
    Nagy B; Szélig L; Rendeki S; Loibl C; Rézmán B; Lantos J; Bogár L; Csontos C
    J Crit Care; 2015 Feb; 30(1):162-6. PubMed ID: 25155253
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Platelet count decline: an early prognostic marker in critically ill patients with prolonged ICU stays.
    Moreau D; Timsit JF; Vesin A; Garrouste-Orgeas M; de Lassence A; Zahar JR; Adrie C; Vincent F; Cohen Y; Schlemmer B; Azoulay E
    Chest; 2007 Jun; 131(6):1735-41. PubMed ID: 17475637
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prognostic value of N terminal pro B type natriuretic peptide in critically ill patients].
    Li ZH; Xiao J; Li JZ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Mar; 23(3):179-82. PubMed ID: 21366951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concentration of gelatinases and their tissue inhibitors in pancreatic inflammatory and neoplastic tumors and their influence on the early postoperative course.
    Lekstan A; Olakowski M; Jabłońska B; Łabuzek K; Olakowska E; Filip I; Lampe P
    Pol Przegl Chir; 2013 Feb; 85(2):65-72. PubMed ID: 23585206
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia.
    Lorenzl S; Buerger K; Hampel H; Beal MF
    Int Psychogeriatr; 2008 Feb; 20(1):67-76. PubMed ID: 17697439
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of a vegetable extract from Lupinus albus (LU105) on the production of matrix metalloproteinases (MMP1, MMP2, MMP9) and tissue inhibitor of metalloproteinases (TIMP1, TIMP2) by human gingival fibroblasts in culture.
    Gaultier F; Foucault-Bertaud A; Lamy E; Ejeil AL; Dridi SM; Piccardi N; Piccirilli A; Msika P; Godeau G; Gogly B
    Clin Oral Investig; 2003 Dec; 7(4):198-205. PubMed ID: 12802622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of Matrix Metalloproteinase-2 (MMP-2) and -9 (MMP-9) and Their Tissue Inhibitors (TIMP-1 and TIMP-2) in Plasma from Patients with Neurodegenerative Dementia.
    Tuna G; Yener GG; Oktay G; İşlekel GH; Kİrkalİ FG
    J Alzheimers Dis; 2018; 66(3):1265-1273. PubMed ID: 30412498
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm.
    Saracini C; Bolli P; Sticchi E; Pratesi G; Pulli R; Sofi F; Pratesi C; Gensini GF; Abbate R; Giusti B
    J Vasc Surg; 2012 Jan; 55(1):171-179.e2. PubMed ID: 22094117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular aspects of collagenolysis associated with stress urinary incontinence in women with urethral hypermobility vs intrinsic sphincter deficiency.
    Candoso B; Meneses MJ; Alves MG; Sousa M; Oliveira PF
    Neurourol Urodyn; 2019 Aug; 38(6):1533-1539. PubMed ID: 31099099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.